Dr Kate Stringaris, Consultant Haematologist
Dr Kate Stringaris
Consultant Haematologist
Dr Kate Stringaris MB BS (MD) BSc MRCP FRCPath PhD
Consultant Haematologist
Dr Kate Stringaris
Consultant Haematologist MB BS (MD) BSc MRCP FRCPath PhD
Dr Stringaris is a Consultant Haematologist
Areas of expertise
- Leukemia
- Myelodysplastic syndrome
- Cellular therapies
- Haematology
- Novel immune therapies for acute myeloid leukemia
Make an appointment
Address
-
HCA UK at University College Hospital
15th Floor, University College Hospital, 235 Euston Road, London, NW1 2BU
-
Telephone or video consultation
Virtual
About Dr Kate Stringaris
GMC number: 4729008
Year qualified: 2000
Place of primary qualification: University of London
Dr Kate Stringaris is an accomplished Consultant Haematologist and Clinician Scientist, currently practising at University College London Hospital. She specialises in treating blood disorders through chemotherapy, cellular therapies, and stem cell transplantation. Dr Stringaris earned her primary medical degree from University College London and completed her general medical training at St George's Hospital. She further honed her expertise in haematology at the Royal Free Hospital and Hammersmith Hospitals.
Dr Stringaris holds a PhD in Leukaemia from Imperial College London and serves as a Senior Clinical Lecturer at St Bart's Hospital in London. Her extensive research focuses on immune defects in leukaemia and transplantation immunology. She has also worked as a senior research physician at the National Heart Lung and Blood Institute, National Institutes of Health in the USA, where she concentrated on natural killer cell immunity and pioneering immune therapies for acute myeloid leukaemia.
Appointed as a Consultant Haematologist in 2023, Dr Stringaris is dedicated to advancing the field of haematology through both clinical practice and research. Her areas of expertise include chemotherapy, cellular therapies and immune therapies. She is particularly interested in the treatment of acute myeloid leukaemia and the development of innovative therapies to improve patient outcomes.
Areas of expertise
- Acute myeloid leukaemia (AML)
- Blood cancer
- Bone marrow tests & biopsies
- Chronic lymphocytic leukaemia
- Haematology
- Leukaemia
- Myelodysplastic syndrome
- Natural killer cell immunity
- Novel immune therapies for acute myeloid leukemia
Professional memberships
Articles by Dr Kate Stringaris
Should child psychiatry be more like paediatric oncology?
The importance of natural killer cell killer immunoglobulin-like receptor-mismatch in transplant outcomes
Intrabone transplantation of CD34+ cells with optimized delivery does not enhance engraftment in a rhesus macaque model
Opportunities and limitations of natural killer cells as adoptive therapy for malignant disease
Orphan NKs! The mystery of the self-renewing NK cells
KIR gene haplotype
Repeated vaccination is required to optimize seroprotection against H1N1 in the immunocompromised host
Optic nerve cyst associated with optic disk pits
Leukemia-induced phenotypic and functional defects in natural killer cells predict failure to achieve remission in acute myeloid leukemia
